Brief: Iveric Bio Announces Positive Topline Data From Zimura® Gather2 Phase 3 Clinical Trial In Geographic Atrophy

IVERIC bio

06/09/2022 12:14

Sept 6 (Reuters) - Iveric Bio Inc  ISEE.O :
    * IVERIC BIO ANNOUNCES POSITIVE TOPLINE DATA FROM ZIMURA®
GATHER2
PHASE 3 CLINICAL TRIAL IN GEOGRAPHIC ATROPHY
    * IVERIC BIO INC - PLAN TO SUBMIT NEW DRUG APPLICATION TO
FDA BY
END OF Q1 2023
    * IVERIC BIO INC - GATHER2 MET ITS PRESPECIFIED PRIMARY
ENDPOINT
OF MEAN RATE OF GROWTH (SLOPE) IN GA AREA AT 12 MONTHS
    * IVERIC BIO INC - STATISTICALLY SIGNIFICANT RESULT WITH
FAVORABLE
SAFETY PROFILE

Source text for Eikon:  ID:nBw7m7m8ra 
Further company coverage:  ISEE.O 

 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))